Related Experiment Video
Updated: May 5, 2026

12:58
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
8.7K
Circulating Growth Differentiation Factor 15 (GDF15) in Paediatric Disease: A Systematic Review.
David W Kronenberger1, Teresa A Zimmers2, Rick K Ralston3
1Indiana University School of Medicine, Indianapolis, Indiana, USA.
Journal of Cachexia, Sarcopenia and Muscle
|February 28, 2025
Summary
Growth Differentiation Factor 15 (GDF15) levels vary in pediatric diseases, with highest levels seen in cardiac arrest and mitochondrial conditions. Standardizing GDF15 measurement is crucial for its clinical use in children.
Area of Science:
- Pediatric Medicine
- Biochemistry
- Inflammation Research
Background:
- Growth Differentiation Factor 15 (GDF15) is an inflammatory marker with roles in metabolism.
- Existing literature on GDF15 in pediatric populations is limited.
- GDF15 is of interest in adult conditions like cancer cachexia and pregnancy.
Purpose of the Study:
- To review and summarize existing pediatric studies on GDF15.
- To describe disease contexts where GDF15 has been investigated in children.
- To identify research gaps and suggest future directions for GDF15 in pediatrics.
Main Methods:
- Systematic review following PRISMA-ScR guidelines.
- Searched Ovid MEDLINE, Embase, Cochrane Library, and Scopus.
- Included studies measuring GDF15 in individuals from birth to 18 years old.
Main Results:
- Analyzed 62 studies across various pediatric conditions (cardiac, endocrine, oncologic, etc.).
- Highest median GDF15 levels were found in cardiac arrest and mitochondrial diseases.
- GDF15 levels can normalize with treatment in conditions like Kawasaki Disease and PCOS.
Conclusions:
- GDF15 has been studied in diverse pediatric diseases.
- Methodological variability hinders direct comparison of GDF15 studies.
- Standardized GDF15 measurement is needed to clarify its diagnostic utility and therapeutic potential in children.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Role of Hematopoietic Growth Factors
3.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.9K

